Vivera Pharmaceuticals Granted Allowance for ZICOH® Patent

NEWPORT BEACH, Calif.: NEWPORT BEACH, Calif., May 20, 2021 /PRNewswire/ -- Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent for ZICOH®. Designed to better facilitate patient-provider interactions and play a role in reducing prescription opioid abuse, the ZICOH® device and its software...

Click to view original post